ALACHUA, FL / ACCESSWIRE / May 30, 2019 / CTD Holdings, Inc. (OTCQB: CTDH) (”CTD” or the ”Company”), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, announces a private placement to raise approximately $7.2 million. CTD will use the proceeds from the transaction as growth capital and for general corporate purposes.

CTD will issue 28,770,000 shares at a price of $0.25 per share and accompanying warrant, resulting in gross proceeds to the Company of $7,192,500, before fees and expenses. In addition, the Company will issue 28,770,000 warrants with a strike price of $0.30 per share and a five and a half-year term.

The securities sold in the transaction have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or state securities laws and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission or an applicable exemption from such registration requirements.

This press release has been issued pursuant to Rule 135c under the Securities Act and does not constitute an offer to sell or the solicitation of an offer to buy the securities, nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state.

About CTD Holdings:

CTD Holdings, Inc. is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is used to treat Niemann-Pick Disease Type C, a rare and fatal genetic disease, on a compassionate use basis as well as in three ongoing formal clinical trials (Clinical Trials.gov NCT02939547 , NCT02912793 and NCT03893071). Additional indications for the active ingredient in Trappsol® Cyclo™ are in development. For additional information, visit the company’s website: www.ctd-holdings.com.

Safe Harbor Statement:

This press release contains ”forward-looking statements” about the company’s current expectations about future results, performance, prospects and opportunities. Statements that are not historical facts, such as ”anticipates,” ”believes” and ”expects” or similar expressions, are forward-looking statements. These statements are subject to a number of risks, uncertainties and other factors that could cause actual results in future periods to differ materially from what is expressed in, or implied by, these statements. The factors which may influence the company’s future performance include the company’s ability to obtain additional capital to expand operations as planned, success in achieving regulatory approval for clinical protocols, enrollment of adequate numbers of patients in clinical trials, unforeseen difficulties in showing efficacy of the company’s biopharmaceutical products, success in attracting additional customers and profitable contracts, and regulatory risks associated with producing pharmaceutical grade and food products. These and other risk factors are described from time to time in the company’s filings with the Securities and Exchange Commission, including, but not limited to, the company’s reports on Forms 10-K and 10-Q. Unless required by law, the company assumes no obligation to update or revise any forward-looking statements as a result of new information or future events.

Investor/Media Contact:

Sitrick and Company

Wendy Tanaka
(415) 369-8447
wtanaka@sitrick.com

SOURCE: CTD Holdings, Inc.

ReleaseID: 547124

LOS ANGELES, CA / ACCESSWIRE / May 30, 2019 / iConsumer Corp. (OTCQB: RWRDP) where tens of thousands of ordinary consumers are rewarded publicly-traded equity – RWRDP, simply for shopping at their favorite retailers, today announced that it will be presenting at the 9th annual LD Micro Invitational on Thursday, June 5 at 8:00 AM PST / 11:00 AM EST. Co-founder and CEO Robert Grosshandler will be presenting and meeting with investors.

In keeping with SEC Chairman Jay Clayton’s call for more retail investor involvement with early-stage companies, iConsumer makes every customer a shareholder when they earn rewards by shopping at over 2,000 great online retailers.

“We’re pleased to return to the LD Micro Invitational” stated Robert Grosshandler. “The first time we were here we were still a private company. Now we’ve used Reg. A+ to become a pre-IPO public company. Our 2,700+ shareholders of record, plus over 50,000 shareholders in waiting, expect us to conquer the world as we work, with their participation, to build a publicly-traded massive company in the rewards and loyalty market space. Presenting at this conference is one way we help our shareholders understand what it takes to build a publicly-traded early stage startup.”

To receive additional information or to schedule a one-on-one meeting with iConsumer, please contact Hayden IR at 917-658-7878.

The LD Micro Invitational will take place June 4th and 5th in Los Angeles, at the Luxe Sunset Bel Air Hotel, will feature 230 companies, and will be attended by over 1,000 individuals.

View iConsumer profile here: http://www.ldmicro.com/rwrdp.

Profiles powered by LD Micro – News Compliments of Accesswire

About iConsumer

Headquartered in Evanston, Illinois, iConsumer Corp. (OTCQB: RWRDP ) is the next generation loyalty and rewards platform that helps its members understand and participate in the stock market. Consumers are rewarded with publicly-traded equity – RWRDP – whenever they shop at 2,000 participating retailers. Retailers pay iConsumer for bringing those customers to them. iConsumer is heeding SEC Chairman Jay Clayton’s April 2019 call for “companies to access the public capital markets earlier in their life cycle”. iConsumer is the early-stage company focused on giving ordinary people the experience of being a public company shareholder, simply because they shopped.

For additional information, please visit us at: https://www.iConsumer.com.

Forward-Looking Statements

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. Except as may be required by applicable law, we assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The company undertakes no duty to update forward-looking statements.

Offering Statement on File

AN OFFERING STATEMENT REGARDING THIS OFFERING HAS BEEN FILED WITH THE SEC. THE SEC HAS QUALIFIED THAT OFFERING STATEMENT, WHICH ONLY MEANS THAT THE COMPANY MAY MAKE SALES OF THE SECURITIES DESCRIBED BY THE OFFERING STATEMENT. IT DOES NOT MEAN THAT THE SEC HAS APPROVED, PASSED UPON THE MERITS OR PASSED UPON THE ACCURACY OR COMPLETENESS OF THE INFORMATION IN THE OFFERING STATEMENT. YOU MAY OBTAIN A COPY OF THE OFFERING CIRCULAR THAT IS PART OF THAT OFFERING STATEMENTAT https://www.iconsumer.com/offeringcircular.

YOU SHOULD READ THE OFFERING CIRCULAR BEFORE MAKING ANY INVESTMENT.

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space.

What started out as a newsletter highlighting unique companies has transformed into several influential events annually (Invitational, Summit, and Main Event).

In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and micro-cap universe.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

Contact:

Name: Robert Grosshandler
Phone: 888-546-7980
Address: 73 Greentree Drive, #558
Dover, DE 19904
Email: rob@iConsumer.com

SOURCE: iConsumer Corp

ReleaseID: 547073

TORONTO, ON / ACCESSWIRE / May 30, 2019 / SusGlobal Energy Corp. (“SusGlobal”) or (the “Company”) (OTCQB: SNRG), the developer of SusGro™, a revolutionary pathogen-free organic liquid fertilizer, today announced that its wholly-owned subsidiary, SusGlobal Energy Belleville Ltd. (“SusGlobal Belleville”), has executed a Share Purchase Agreement (the “SPA”) for certain assets (the “Assets”), including 42.18 acres of property (the “Property”) located at 704 Phillipston Road, in Belleville, Ontario.

As per the terms of the SPA the Company paid a purchase price of USD$1,314,723 (CAD$1,767,250) in cash with USD$1,261,159 (CAD$1,695,250) paid on closing. As previously disclosed in a press release dated February 20, 2019, the amount of USD$54,274 (CAD$72,000) was advanced by the Company to the seller on February 5th.

SusGlobal is now the owner of the 42.18-acre land parcel and no longer a lessee of the 13.88-acre portion. SusGlobal Belleville will continue producing its Earth’s Journey™ Compost by processing 70,000 tonnes per annum of organic waste, with an additional 50,000 tonnes per annum organic waste processing and transfer site approved under the existing Environmental Compliance Approval (the “ECA”) and Site Plan. The integration of processing equipment into the existing facilities will also allow for the treating of source separated organics (“SSO”) and industrial, commercial and institutional (“ICI”) organic wastes to produce a high yield organic slurry which will be sent to local anaerobic digesters to produce energy, while continuing to reduce greenhouse gas emissions (“GHG”) by diverting organic waste from landfills.

“We are pleased to have purchased this large parcel of land with the ECA attached in order to continue our initiatives at the Belleville site to bring organic waste management systems to a sustainable level by diverting from landfills and producing regenerative products,” stated Marc Hazout, Executive Chairman and President of SusGlobal Energy Corp.

The details of the SPA are found in the Current Report on Form 8-K that the Company filed with the Securities and Exchange Commission on May 30, 2019.

About SusGlobal Energy Corp.

SusGlobal Energy Corp., the developer of SusGro™, a revolutionary pathogen-free organic liquid fertilizer is a renewables company focused on acquiring, developing and monetizing a portfolio of proprietary technologies in the waste to energy and regenerative products application globally. It is management’s objective to grow SusGlobal into a significant sustainable waste to energy and regenerative products provider, as Leaders in The Circular Economy™. For more information, please visit the Company’s website at: www.susglobalenergy.com

Safe Harbor Statement

This news release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s objectives. Forward looking statements are statements that are not historical facts and are generally, but not always, identified by the words “expects,” “plans,” “anticipates,” “believes,” “intends,” “estimates,” “projects,” “aims,” “potential,” “goal,” “objective,” “prospective,” and similar expressions, or that events or conditions “will,” “would,” “may,” “can,” “could” or “should” occur. The Company cautions investors that any forward-looking statements by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking statements as a result of various factors, including, but not limited to, lack of sufficient financial resources; variations in market conditions, currency and our stock; the Company’s ability to obtain any necessary permits, approvals, consents or authorizations required for its activities; the Company’s ability to produce energy, biogas, compost or organic fertilizer from its properties successfully or profitably, to continue its projected growth, or to be fully able to implement its business strategies and other risk factors described in the Company’s filings with the U.S. Securities and Exchange Commission, which may be viewed at www.sec.gov.

Contact

SusGlobal Energy Corp.
Marc Hazout, President
(416) 223-8500 or Toll Free: 1-866-512-7374
Email: info@susglobalenergy.com

SOURCE: SusGlobal Energy Corp.

ReleaseID: 547042

TORONTO, ON / ACCESSWIRE / May 30, 2019 / Kontrol Energy Corp. (CSE: KNR, OTCQB: KNRLF, FSE:1K8) (“Kontrol” or “Company”) has secured a new contract with a Cannabis producer in the province of Ontario. Under this agreement, Kontrol Energy will provide energy, emission and odor compliance services for the Canadian cannabis licensed cultivator.

For industry competitive purposes the customer will not be disclosed. The customer is in the process of retrofitting its facility to expand its cannabis cultivation operations.

“Energy costs can account for up to 50% of the input costs for a licensed producer. Through our ability to design and implement energy savings technologies and solutions we continue to grow our footprint in the Cannabis sector”, said Paul Ghezzi, CEO of Kontrol Energy. “In addition, the requirement to comply with changing local emission and odor regulations is an area where Kontrol and its subsidiaries have a great deal of history in helping our customers be at the leading edge of compliance.”

Through its real-time energy management software and vertically integrated technology and services, Kontrol provides cannabis cultivators with the opportunity to reduce their energy costs to be a viable low-cost operator. As the industry continues to face cost pressures, those cultivators who are at the leading edge of reducing their energy costs will gain a competitive advantage.

About Kontrol Energy

Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.

Kontrol Energy was recently announced as the 7th fastest growing Startup in Canada by Canadian Business and Maclean’s.

Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com

For further information, contact us at admin@kontrolenergy.com Kontrol Energy Corp., 180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8 Tel: 905.766.0400, Toll free: 1.844.566.8123

For further information, contact:

Paul Ghezzi, Chief Executive Officer
paul@kontrolenergy.com
Kontrol Energy Corp.,
180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8
Tel: 905.766.0400, Toll free: 1.844.566.8123

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Information

Certain information included in this press release, including information relating to energy analytics, growth and expansion of the cannabis sector, the provision of solutions to customers to analyze the management of complex Emission and Odour testing and compliance, growth strategy, targeted expansion and other statements that express the expectations of management or estimates of future performance constitute “forward-looking statements”. The forward-looking statements in this press release are presented for the purpose of providing information about management’s current expectations and plans and such information may not be appropriate for other purposes. Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief are based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that the acquisition will be successfully integrated into the Company and that its revenues will be consistent with the Company’s expectations, that suitable businesses and technologies for acquisition and/or investment will be available, that such acquisitions and or investment transactions will be concluded, that sufficient capital will be available to the Company, that technology will be as effective as anticipated, that organic growth will occur, and others. However, forward-looking statements are subject to risks, uncertainties and other factors, which could cause actual results to differ materially from future results expressed, projected or implied by such forward-looking statements. Such risks include, but are not limited to, lack of acquisition and investment opportunities or that such opportunities may not be concluded on reasonable terms, or at all, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and the Company does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise, except as required under applicable securities law.

SOURCE: Kontrol Energy Corp.

ReleaseID: 547096

VANCOUVER, BC / ACCESSWIRE / May 30, 2019 / RESAAS Services Inc. (TSX-V: RSS, OTCQB: RSASF) President and CEO, Tom Rossiter, is pleased to report highlights from our Q1 2019 financials:

Increased revenue by 86%, year-over-year from 2018
Decreased expenses by 67%, year-over-year from 2018
Decreased net loss and comprehensive loss by 75%, year-over-year from 2018

Q1 2019 marks our strongest quarter to date with the highest revenue and lowest operating expenses.

In late 2018, RESAAS made a number of corporate and operational changes that have already proven to be positive driving forces for the Company. In October 2018, RESAAS appointed Pierre Chadi as the Company’s Chairman of the Board. Mr. Chadi is an accomplished bilingual senior executive with 19 years spent as Director of Eastern Region with Microsoft Canada. He has over 30 years leadership experience in technology enterprise sales and Software-As-A-Service (SaaS) Cloud Offerings, as well as well as over 20 years of active investor experience focused on early stage SaaS companies.

In November 2018, RESAAS appointed Annie Chan as the Company’s Chief Financial Officer. Ms. Chan is a Chartered Professional Accountant and Chartered Accountant with 12 years of experience working for publicly listed companies in technology, telecommunication, banking and mining. Ms. Chan helped bring these companies to their successful exit. Most recently, Ms. Chan was the Chief Financial Officer for a gigabit internet service provider where she oversaw the mergers & acquisition process that led to its acquisition in 2017. Since Ms. Chan’s appointment, she has reduced the Company’s operating expenditures by reducing non essential services. She has also been working with the Company’s COO to analyze user engagement to drive revenue, and working with the Company’s CEO on all corporate and legal initiatives.

In May 2019, RESAAS appointed Sascha Williams as the Company’s Chief Operating Officer. Mr. Williams is a seasoned technology entrepreneur, with a particular focus on building recurring revenue businesses. Most recently, Mr. Williams served as President & COO of Unbounce, one of Canada’s top performing SaaS companies with 175 employees in Vancouver and Berlin. Mr. Williams also held director positions at Disney Interactive, Electronic Arts and Big Park, leading up to its acquisition by Microsoft. Since Mr. William’s appointment, he has been working with the Company to increase user engagement through a deep dive analysis of user activities on the RESAAS Platform, and then subsequently designing features to enhance user engagement.

RESAAS monetized new revenue channels including the launch of an advertising division. Corporations wishing to access the real estate market can leverage RESAAS’ own proprietary advertising solution, AdSAAS, to run ads, target specific types of agents and reach particular markets where there is a direct reach to over 460,000 worldwide licensed real estate agents. Aviva Canada, one of the leading property insurance groups in Canada, became our newest client.

RESAAS partnered with eCommission to launch industry-first advances on referral fees. eCommission will provide advances to agents conducting their referral business within the RESAAS platform and the Company will be compensated for all advances generated from this relationship.

RESAAS is increasing both the breadth of revenue to drive MRR, and the depth of revenue to drive user engagement. We continue to be cost aware as we grow our business, and we continue to be a custodian of vast amounts of unique real estate data. Management and the Board look forward to share further successes with our Shareholders over the weeks and months ahead.

###

About RESAAS Services Inc.
RESAAS is a cloud-based and blockchain technology platform that enables real estate brokerages, franchises and associations to bring real-time communication, new business opportunities and unique data to their agents on a global basis.

Visit www.resaas.com for more information.

For further information contact:
Tom Rossiter, CEO
RESAAS Services Inc.
Tel: +1 (604) 558-2929 Email: investors@resaas.com

The TSX Venture Exchange has neither approved nor disapproved the contents of this news release. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The statements made in this news release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from RESAAS Services Inc.’s expectations and projections.

SOURCE: RESAAS Services Inc.

ReleaseID: 547110

Almost 6 Million Users And Former Users Of The J&J/Lifescan Meters Can Choose Between Using Genultimate TBG Test Strips With Their Older Meters, Or Choose, In A Company Sponsored Merchandising Initiative, To Receive A TBG Precise Meter Free Of Charge

LOS ANGELES, CA / ACCESSWIRE / May 30, 2019 / Decision Diagnostics Corp. (OTC PINK: DECN) is a 17 year old, diabetes-focused bio-technology R&D firm, manufacturer, quality plan administrator, FDA registered medical device customer support organization, and exclusive worldwide sales and regulatory process agent for the GenUltimate! (“Sunshine”) diabetes test strip, the internationally launched GenSure! (“Feather”) diabetes test strip, and its GenChoice! (“Ladybug”) test strip now under review for FDA 510K clearance. The company also markets the PetSure! test strip for the diabetic testing of dogs and cats, a diagnostic specifically designed to run on the market leading Zoetis Alpha Trak meter system, and the GenUltimate! Test 4Pets test strip and Avantage! meter launched earlier in 2019, and the panacea GenUltimate! TBG (“Dragonfly”) highly precise diabetes testing system, launching on June 6, 2019, in select off-shore markets.

As we have stated, GenUltimate TBG along with its Precise glucometer will be launched internationally with a focus on the estimated 4 million users and 1.8 million former users of the renowned OneTouch Ultra family of meters. Customers will have two paths to choose from with GenUltimate TBG. Customers can choose to use or again put to use their Lifescan Ultra meters with the GenUltimate TBG test strip, which remains 100% compatible with these meters, and as a result receive an up to 75% improvement in precision and accuracy of their blood glucose readings, making GenUltimate TBG the first major improvement in this venerable technology since 2008. Or the customer can opt to swap their J&J/Lifescan meter for our GenUltimate Precise meter, free of charge, and receive all of the features we have discussed in previous news. Our Powerpoint presentation and the important third party testing statistics, for GenUltimate TBG will be posted on www.decisiondiagnostics.com and www.pharmatechdirect.com. The International packaging for GenUltimate TBG will be five language, English (side 1), Spanish, French, German, Portuguese (side 2).

Keith Berman, CEO of Decision Diagnostics comments, “We have great anticipation for our upcoming launch of GenUltimate TBG. We have worked on this product and its predecessor cousin for almost three years, and finally our day has arrived. GenUltimate TBG will reset the market standard which is currently based on the concepts of ease of use and familiarity with standards that for the most part are 15 years old, to our concept which will be ease of use, familiarity and market moving accuracy and precision.”

Field and third party testing of GenUltimate TBG, has obtained verifiable accuracy data showing that even without the TBG features employed, using stock J&J Lifescan meters, GenUltimate TBG achieved repeatable accuracy of +/- 9%, over 95% of the time. When using our GenUltimate TBG Precise meter with the TBG test strips our accuracy becomes an almost unbelievable +/- 7%, more than 97% of the time, while correcting for HCT interference. To augment our filings with government agencies, we intend to complete two clinical studies, one study using 150 donors, and other using 250 donors. The first clinical will begin immediately, the other as soon as we receive quantities of our GenUltimate TBG Precise meters.

Mr. Berman continued, “We anticipate filing a 510(k) submission for our TBG system, with the U.S. FDA, later this summer. In the meantime, we will continue to circle around three important and related tasks:

Demonstrate the GenUltimate TBG and its Precise meter to Big Box customers CVS, Walmart, McKesson and Walgreens.
File patent abstracts with the USPTO, patenting our GenUltimate test strip and Precise meter technologies
Work out the details for an upcoming investment, license or M&A transaction.

We have a full summer ahead of us. And for those interested, we plan to adapt the TBG technology to our GenChoice test strip, completing that project, and then watching the effect it will have on another major industry player. The Board is keeping its options open as our journey moves on.”

ABOUT DECISION DIAGNOSTICS CORP
Decision Diagnostics Corp. is the leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters. DECN’s products are designed to operate efficiently and less expensively on certain glucose meters already in use by almost 7.5 million diabetics worldwide. With new inspired technology diabetic test strips already in the final stages of development, DECN products compete on a worldwide scale with legacy manufacturers currently selling to 71+ percent of a $12 billion at-home testing market.

Forward-Looking Statements:
This release contains the company’s forward-looking statements which are based on management’s current expectations and assumptions as of May 29, 2019, regarding the company’s business and performance, its prospects, current factors, the economy, and other future conditions and forecasts of future events, circumstances, and results.

CONTACT INFORMATION:

Decision Diagnostics Corp.
Keith Berman (805) 446-2973
info@decisiondiagnostics.com
www.genultimate.com
www.petsureteststrips.com
www.pharmatechdirect.com

SOURCE: Decision Diagnostics Corp.

ReleaseID: 547021

Global Telesat Communications Celebrates 1,300 Unit Milestone as New Motorola Solutions EMEA Channel Partner

AVENTURA, FL / ACCESSWIRE / May 30, 2019 / Orbital Tracking Corp. (OTCQB: TRKK) (“Orbital Tracking” or the “Company”), today announced that its Global Telesat Communications subsidiary has expanded its commercial product portfolio with the addition of top-selling Motorola XT400 Series Business Two-Way Radios, XT600d Series Unlicensed Two-Way Radios and MOTOTRBO™ Digital Portable Radio (DPR) workforce radio products as part of its increasing focus on commercial and enterprise sales.

Having recently been named as a Motorola Solutions EMEA Channel Partner and surpassing a 1,300-unit sales milestone, Global Telesat Communications is one of Europe’s leading providers of Mobile Satellite Services (“MSS”) including satellite enabled tracking, emergency location, and voice/data solutions serving consumers, commercial and government customers throughout Europe. Building on growing demand for wireless business communications in industries ranging from manufacturing and construction to facilities management and security, Global Telesat Communications has expanded its offerings with the introduction of an array of new radio products from Motorola Solutions including the XT460, XT660, DP1400 and SL4000.

“Demand for advanced, easy-to-use radio systems by customers in commercial and industrial sectors continues to grow and with the addition of these new Motorola radio products into our product portfolio, we will be able to serve new and existing customers in these large markets with a wider array of workforce communications solutions,” said David Phipps, Chief Executive Officer of Orbital Tracking.

About Motorola Business Two-Way Radios

Global Telesat Communications (GTC) has introduced Two-Way Business Radios to their portfolio to equip businesses with portable voice solutions across a diverse or dispersed workforce, for greater collaboration and work efficiency.

The Motorola XT400 Series Business Two-Way Radios and XT600d Series Unlicensed Two-Way Radios empowers businesses to communicate instantly with personnel dispersed across warehouses, shop floors or construction sites. These radios operate on license and subscription-free PMR446 frequencies, to meet the European Union standard for radios and enable on-site communications with no call charges – the perfect answer for business users who need to stay in touch with colleagues.

MOTOTRBO™ DP1400 Digital Portable Radios (DPR) connects your entire operation and workforce efficiently through superior audio quality, outstanding coverage and long-lasting battery life, to provide solutions for connecting teams who require reliable communication to coordinate and collaborate with crew members.

MOTOTRBO™ SL4000e Smart Two-Way Radios are designed to provide management with complete control through high-performing, integrated voice and data capabilities to deliver smart connectivity to an organisation. The Motorola SL4000e expands communications across workforces through upgraded audio clarity when used at high-volume construction sites.

About Global Telesat Communications Ltd.

Global Telesat Communications Ltd (GTC), a subsidiary of Orbital Tracking Corp. (OTCQB: TRKK), is a supplier of mobile voice and data communications services via satellite. GTC provides equipment and airtime for use on all the major satellite networks including Globalstar, Inmarsat, Iridium and Thuraya allowing users in remote locations to make phone calls, connect to the internet and track assets or personnel anywhere in the world. For more information regarding GTC, please visit www.globaltelesat.co.uk.

About Orbital Tracking Corp.

Orbital Tracking Corp. provides satellite-based tracking, services as well as mobile voice and data communications services globally via satellite to the commercial and government users. Orbital Tracking specializes in services related to the Globalstar satellite constellation, including ground station construction, simplex tracking services and satellite telecommunications voice airtime. Orbital Tracking operates various e-commerce retail and tracking portals where users around the world can purchase satellite hardware and track assets in real-time on mobile devices or PCs. For more information regarding Orbital Tracking, please visit www.orbitaltracking.com.

Forward-Looking Statements

Certain statements in this release constitute forward-looking statements. These statements include the capabilities and success of the Company’s business and any of its products, services or solutions. The words “believe,” “forecast,” “project,” “intend,” “expect,” “plan,” “should,” “would,” and similar expressions and all statements, which are not historical facts, are intended to identify forward-looking statements. These forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors, any of which could cause the Company to not achieve some or all of its goals or the Company’s previously reported actual results, performance (finance or operating) to change or differ from future results, performance (financing and operating) or achievements, including those expressed or implied by such forward-looking statements. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the SEC, copies of which may be obtained from the SEC’s website at www.sec.gov. The Company assumes no, and hereby disclaims any, obligation to update the forward-looking statements contained in this press release.

Contact:

Michael Glickman
MWGCO, Inc.
917-397-2272
mike@mwgco.net

SOURCE: Orbital Tracking Corp.

ReleaseID: 547121

TORONTO, ON / ACCESSWIRE / May 30, 2019 / Intellipharmaceutics International Inc. (OTCQB: IPCIF and TSX: IPCI) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that the Company’s pre-existing license to conduct activities with Cannabidiol (“CBD”) has been migrated by Health Canada to a Cannabis Drug License (“CDL”) under the Cannabis Regulations.

Intellipharmaceutics’ new CDL allows the Company to continue to possess cannabis, produce a drug containing cannabis and sell a drug containing cannabis in Canada.

The CDL is unique from other forms of cannabis licenses in Canada as, according to Health Canada, it is a requirement for any company that intends to produce and sell a prescription drug containing cannabis or cannabinoids. Only companies, such as Intellipharmaceutics, with a Health Canada issued Drug Establishment License are eligible to apply for a CDL.

“Our receipt of a Cannabis Drug License from Health Canada demonstrates Intellipharmaceutics’ commitment to the research and development of a pipeline of pharmaceutical CBD-based products, but also shows why we believe we are uniquely positioned to bring cannabinoid based, prescription drugs to the Canadian and global markets,” commented Intellipharmaceutics’ CEO, Dr. Isa Odidi.

There can be no assurance that we will be able to develop cannabis-based products or that any cannabis-based product candidates we develop will ever be successfully commercialized or produce significant revenue for us.

About Intellipharmaceutics

Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. The Company’s patented Hypermatrix™ technology is a multidimensional controlled-release drug delivery platform that can be applied to a wide range of existing and new pharmaceuticals. Intellipharmaceutics has developed several drug delivery systems based on this technology platform, with a pipeline of products (some of which have received United States Food and Drug Administration (“FDA”) approval) in various stages of development. The Company has Abbreviated New Drug Application and New Drug Application (“NDA”) 505(b)(2) drug product candidates in its development pipeline. These include the Company’s abuse-deterrent oxycodone hydrochloride extended release formulation (“Oxycodone ER”) based on its proprietary nPODDDS™ novel Point Of Divergence Drug Delivery System (for which an NDA has been filed with the FDA), and Regabatin™ XR (pregabalin extended-release capsules).

Cautionary Statement Regarding Forward-Looking Information

Certain statements in this document constitute “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and/or “forward-looking information” under the Securities Act (Ontario). These statements include, without limitation, statements expressed or implied regarding our expectations regarding our plans, goals and milestones, status of developments or expenditures relating to our business, plans to fund our current activities, and statements concerning our partnering activities, health regulatory submissions, strategy, future operations, future financial position, future sales, revenues and profitability, projected costs and market penetration and risks or uncertainties related to our ability to comply with OTCQB and TSX requirements. In some cases, you can identify forward-looking statements by terminology such as “appear”, “unlikely”, “target”, “may”, “will”, “should”, “expects”, “plans”, “plans to”, “anticipates”, “believes”, “estimates”, “predicts”, “confident”, “prospects”, “potential”, “continue”, “intends”, “look forward”, “could”, “would”, “projected”, “goals”, “set to”, “seeking” or the negative of such terms or other comparable terminology. We made a number of assumptions in the preparation of our forward-looking statements. You should not place undue reliance on our forward-looking statements, which are subject to a multitude of known and unknown risks and uncertainties that could cause actual results, future circumstances or events to differ materially from those stated in or implied by the forward-looking statements. Risks and uncertainties relating to us and our business can be found in the “Risk Factors” section of our latest annual information form, our latest Form 20-F, and our latest Form F-1 and Form F-3 registration statements (including any documents forming a part thereof or incorporated by reference therein), as amended, as well as in our reports, public disclosure documents and other filings with the securities commissions and other regulatory bodies in Canada and the U.S., which are available on www.sedar.com and www.sec.gov. The forward-looking statements reflect our current views with respect to future events and are based on what we believe are reasonable assumptions as of the date of this document and we disclaim any intention and have no obligation or responsibility, except as required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Trademarks used herein are the property of their respective holders.

Unless the context otherwise requires, all references to “we,” “us,” “our,” “Intellipharmaceutics,” and the “Company” refer to Intellipharmaceutics International Inc. and its subsidiaries.

CONTACT INFORMATION

Company Contact:
Intellipharmaceutics International Inc.
Greg Powell
Chief Financial Officer
416.798.3001 ext. 106
investors@intellipharmaceutics.com

Investor Contact:
PCG Advisory
Kirin Smith
646.863.6519
ksmith@pcgadvisory.com

SOURCE: Intellipharmaceutics International Inc.

ReleaseID: 547067